Satellos Bioscience
(NASDAQ) MSLE
Satellos Bioscience Financials at a Glance
Market Cap
$90.74M
Revenue (TTM)
$0.00
Net Income (TTM)
$20.87M
EPS (TTM)
$-1.73
P/E Ratio
-3.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.88
Volume
51,323
Open
$5.95
Price
$5.88
Volume
51,323
Open
$5.95
Previous Close
$5.87
Daily Range
$5.80 - $6.00
52-Week Range
$4.53 - $13.39
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.88
Volume
51,323
Open
$5.95
Previous Close
$5.87
Daily Range
$5.80 - $6.00
52-Week Range
$4.53 - $13.39
MSLE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Satellos Bioscience
Industry
Biotechnology
Sector
Health CareEmployees
18
CEO
Frank Gleeson, MBA
Website
www.satellos.comHeadquarters
Toronto, ON M5J 2J1, CA
MSLE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-66%
Return on Capital
-21%
Return on Assets
-26%
Earnings Yield
-29.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$90.74M
Shares Outstanding
15.46M
Volume
51.32K
Short Interest
0.00%
Avg. Volume
69.46K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$19.38M
EBITDA
$19.56M
Operating Cash Flow
$17.40M
Capital Expenditure
$4.18K
Free Cash Flow
$17.41M
Cash & ST Invst.
$48.67M
Total Debt
$0.00
Satellos Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$90.74M
N/A
Market Cap/Employee
$6.48M
N/A
Employees
14
N/A
Net Income
$5.82M
+12.1%
EBITDA
$5.96M
-61.2%
Quarterly Fundamentals
Net Cash
$34.61M
+99.7%
Accounts Receivable
$205.00K
+45.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-25.56%
N/A
Return on Invested Capital
-20.67%
N/A
Free Cash Flow
$4.13M
-27.5%
Operating Cash Flow
$4.13M
-27.4%